The neurotrophin-3 inhibitor LEVI-04 relieves pain for patients with osteoarthritis and the study drug was well tolerated ...

Neurotrophin-3 (NT-3) inhibitor LEVI-04 hit all its primary and secondary objectives in the trial, which enrolled 510 patients with moderate-to-severe osteoarthritis of the knee, raising the hope ...

WASHINGTON — Investigational treatments aimed specifically at reducing pain in knee osteoarthritis ... investigational agent called LEVI-04, a first-in-class neurotrophin receptor fusion ...